Enhanced efficacy of IL-15-based ALT-803 superagonist complex in combination with immune checkpoint inhibitors in hematologic and metastatic mouse tumor models

Benzer Materyaller

• Enhanced efficacy of ALT-803, an IL-15-based superagonist complex, in combination with immune checkpoint inhibitors in an orthotopic muscle invasive bladder tumor model in mice
  Yazar:: Xu, Wenxin, ve diğerleri
  Baskı/Yayın Bilgisi: (2015)
• CITN-06: a Phase I/expansion trial of alt-803, an IL-15 superagonist, in patients with advanced melanoma
  Yazar:: Margolin, Kim, ve diğerleri
  Baskı/Yayın Bilgisi: (2014)
• IL15N72D superagonist/IL15Rα-Fc fusion complex (ALT-803) exhibits anti-metastatic activity in murine breast tumor model
  Yazar:: Kim, Peter S, ve diğerleri
  Baskı/Yayın Bilgisi: (2015)
• The IL-15 superagonist ALT-803 enhances anti-CD20 antibody-directed NK cell ADCC and in vivo clearance of B cell lymphomas
  Yazar:: Rosario, Maximillian, ve diğerleri
  Baskı/Yayın Bilgisi: (2014)
• Combinatorial therapy with an IL-15 superagonist (ALT-803) and anti-PD-L1 mAb augment T cell mediated anti-tumor immunity in mice
  Yazar:: Johnson, Christopher B, ve diğerleri
  Baskı/Yayın Bilgisi: (2014)